Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis

Journal of Internal Medicine

Volumn 269, Issue 2, 2011, Pages 200-210

  Agardh, H E ^a   Folkersen, L ^a   Ekstrand, J ^a   Marcus, D ^a   Swedenborg, J ^a   Hedin, U ^a   Gabrielsen, A ^a   Paulsson Berne, G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atherosclerosis; Inflammation; Leucocytes; Molecular medicine; Stroke

Indexed keywords

ADIPOPHILIN; ARACHIDONATE 5 LIPOXYGENASE; CD163 ANTIGEN; CD36 ANTIGEN; CD52 ANTIGEN; CD68 ANTIGEN; FATTY ACID BINDING PROTEIN 4; LEUKOTRIENE A4 HYDROLASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INFLAMMATION; LIPID STORAGE; LIPID TRANSPORT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC STRESS; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 78651106820     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02304.x     Document Type: Article

References (22)

1. Corti R, Hutter R, Badimon JJ, Fuster V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis 2004; 17: 35-44.
2. Giles MF, Rothwell PM. Prediction and prevention of stroke after transient ischemic attack in the short and long term. Expert Rev Neurother 2006; 6: 381-95.
3. Hobson RW 2nd, Mackey WC, Ascher E et al. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg 2008; 48: 480-6.
4. Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577-617.
5. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.
6. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
7. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274: 1377-9.
8. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 2008; 7: 489-503.
9. Erbay E, Babaev VR, Mayers JR et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med 2009; 15: 1383-91.
10. The ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
11. Qiu H, Gabrielsen A, Agardh HE et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA 2006; 23: 8161-6.
12. Irizarry RA, Hobbs B, Collin F et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-64.
13. Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM. Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA 1986; 83: 3786-90.
14. Yeung DC, Xu A, Cheung CW et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 1796-802.
15. Zimmer JS, Dyckes DF, Bernlohr DA, Murphy RC. Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products. J Lipid Res 2004; 45: 2138-44.
16. Johnson JL, Newby AC. Macrophage heterogeneity in atherosclerotic plaques. Curr Opin Lipidol 2009; 20: 370-8.
17. Osterborg A, Fassas AS, Anagnostopoulos A, Dyer MJ, Catovsky D, Mellstedt H. Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukaemia. Br J Haematol 1996; 93: 151-3.
18. Rolph MS, Young TR, Shum BO et al. Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2. J Immunol 2006; 177: 7794-801.
19. Tupin E, Nicoletti A, Elhage R et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 2004; 199: 417-22. Epub 2004 Jan 26.
20. Ijas P, Nuotio K, Saksi J et al. Microarray analysis reveals overexpression of CD163 and HO-1 in symptomatic carotid plaques. Arterioscler Thromb Vasc Biol 2007; 27: 154-60. .
21. Martin-Fuentes P, Civeira F, Recalde D et al. Individual variation of scavenger receptor expression in human macrophages with oxidized low-density lipoprotein is associated with a differential inflammatory response. J Immunol 2007; 179: 3242-8.
22. Hellings WE, Moll FL, de Vries J-PPM, de Bruin P, de Kleijn DPV, Pasterkamp G. Histological characterization of restenotic carotid plaques in relation to recurrence interval and clinical presentation: a cohort study. Stroke 2008; 39: 1029-32. .